Eintrag weiter verarbeiten
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients
Gespeichert in:
| Zeitschriftentitel: | The Journal of Clinical Hypertension |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | The Journal of Clinical Hypertension, 21, 2019, 9, S. 1308-1314 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
McDonell, Katherine E. Preheim, Brock A. Diedrich, Andre’ Muldowney, James A. S. Peltier, Amanda C. Robertson, David Biaggioni, Italo Shibao, Cyndya A. McDonell, Katherine E. Preheim, Brock A. Diedrich, Andre’ Muldowney, James A. S. Peltier, Amanda C. Robertson, David Biaggioni, Italo Shibao, Cyndya A. |
|---|---|
| author |
McDonell, Katherine E. Preheim, Brock A. Diedrich, Andre’ Muldowney, James A. S. Peltier, Amanda C. Robertson, David Biaggioni, Italo Shibao, Cyndya A. |
| spellingShingle |
McDonell, Katherine E. Preheim, Brock A. Diedrich, Andre’ Muldowney, James A. S. Peltier, Amanda C. Robertson, David Biaggioni, Italo Shibao, Cyndya A. The Journal of Clinical Hypertension Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Internal Medicine |
| author_sort |
mcdonell, katherine e. |
| spelling |
McDonell, Katherine E. Preheim, Brock A. Diedrich, Andre’ Muldowney, James A. S. Peltier, Amanda C. Robertson, David Biaggioni, Italo Shibao, Cyndya A. 1524-6175 1751-7176 Wiley Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Internal Medicine http://dx.doi.org/10.1111/jch.13619 <jats:title>Abstract</jats:title><jats:p>Orthostatic hypotension (OH) is a common cause of hospitalization, particularly in the elderly. Hospitalized patients with OH are often severely ill, with complex medical comorbidities and high rates of disability. Droxidopa is a norepinephrine precursor approved for the treatment of neurogenic OH (nOH) associated with autonomic failure that is commonly used in the outpatient setting, but there are currently no data regarding the safety and efficacy of droxidopa initiation in medically complex patients. We performed a retrospective review of patients started on droxidopa for refractory nOH while hospitalized at Vanderbilt University Medical Center between October 2014 and May 2017. Primary outcome measures were safety, change in physician global impression of illness severity from admission to discharge, and persistence on medication after 180‐day follow‐up. A total of 20 patients were identified through chart review. Patients were medically complex with high rates of cardiovascular comorbidities and a diverse array of underlying autonomic diagnoses. Rapid titration of droxidopa was safe and well tolerated in this cohort, with no cardiovascular events or new onset arrhythmias. Supine hypertension requiring treatment occurred in four patients. One death occurred during hospital admission due to organ failure associated with end‐stage amyloidosis. Treating physicians noted improvements in presyncopal symptoms in 80% of patients. After 6 months, 13 patients (65%) continued on droxidopa therapy. In a retrospective cohort of hospitalized, severely ill patients with refractory nOH, supervised rapid titration of droxidopa was safe and effective. Treatment persistence was high, suggesting that symptomatic benefit extended beyond acute intervention.</jats:p> Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients The Journal of Clinical Hypertension |
| doi_str_mv |
10.1111/jch.13619 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qY2guMTM2MTk |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qY2guMTM2MTk |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Wiley, 2019 |
| imprint_str_mv |
Wiley, 2019 |
| issn |
1524-6175 1751-7176 |
| issn_str_mv |
1524-6175 1751-7176 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
mcdonell2019initiationofdroxidopaduringhospitaladmissionformanagementofrefractoryneurogenicorthostatichypotensioninseverelyillpatients |
| publishDateSort |
2019 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
The Journal of Clinical Hypertension |
| source_id |
49 |
| title |
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_unstemmed |
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_full |
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_fullStr |
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_full_unstemmed |
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_short |
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_sort |
initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| topic |
Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Internal Medicine |
| url |
http://dx.doi.org/10.1111/jch.13619 |
| publishDate |
2019 |
| physical |
1308-1314 |
| description |
<jats:title>Abstract</jats:title><jats:p>Orthostatic hypotension (OH) is a common cause of hospitalization, particularly in the elderly. Hospitalized patients with OH are often severely ill, with complex medical comorbidities and high rates of disability. Droxidopa is a norepinephrine precursor approved for the treatment of neurogenic OH (nOH) associated with autonomic failure that is commonly used in the outpatient setting, but there are currently no data regarding the safety and efficacy of droxidopa initiation in medically complex patients. We performed a retrospective review of patients started on droxidopa for refractory nOH while hospitalized at Vanderbilt University Medical Center between October 2014 and May 2017. Primary outcome measures were safety, change in physician global impression of illness severity from admission to discharge, and persistence on medication after 180‐day follow‐up. A total of 20 patients were identified through chart review. Patients were medically complex with high rates of cardiovascular comorbidities and a diverse array of underlying autonomic diagnoses. Rapid titration of droxidopa was safe and well tolerated in this cohort, with no cardiovascular events or new onset arrhythmias. Supine hypertension requiring treatment occurred in four patients. One death occurred during hospital admission due to organ failure associated with end‐stage amyloidosis. Treating physicians noted improvements in presyncopal symptoms in 80% of patients. After 6 months, 13 patients (65%) continued on droxidopa therapy. In a retrospective cohort of hospitalized, severely ill patients with refractory nOH, supervised rapid titration of droxidopa was safe and effective. Treatment persistence was high, suggesting that symptomatic benefit extended beyond acute intervention.</jats:p> |
| container_issue |
9 |
| container_start_page |
1308 |
| container_title |
The Journal of Clinical Hypertension |
| container_volume |
21 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792348061878452224 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T18:05:11.659Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Initiation+of+droxidopa+during+hospital+admission+for+management+of+refractory+neurogenic+orthostatic+hypotension+in+severely+ill+patients&rft.date=2019-09-01&genre=article&issn=1751-7176&volume=21&issue=9&spage=1308&epage=1314&pages=1308-1314&jtitle=The+Journal+of+Clinical+Hypertension&atitle=Initiation+of+droxidopa+during+hospital+admission+for+management+of+refractory+neurogenic+orthostatic+hypotension+in+severely+ill+patients&aulast=Shibao&aufirst=Cyndya+A.&rft_id=info%3Adoi%2F10.1111%2Fjch.13619&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792348061878452224 |
| author | McDonell, Katherine E., Preheim, Brock A., Diedrich, Andre’, Muldowney, James A. S., Peltier, Amanda C., Robertson, David, Biaggioni, Italo, Shibao, Cyndya A. |
| author_facet | McDonell, Katherine E., Preheim, Brock A., Diedrich, Andre’, Muldowney, James A. S., Peltier, Amanda C., Robertson, David, Biaggioni, Italo, Shibao, Cyndya A., McDonell, Katherine E., Preheim, Brock A., Diedrich, Andre’, Muldowney, James A. S., Peltier, Amanda C., Robertson, David, Biaggioni, Italo, Shibao, Cyndya A. |
| author_sort | mcdonell, katherine e. |
| container_issue | 9 |
| container_start_page | 1308 |
| container_title | The Journal of Clinical Hypertension |
| container_volume | 21 |
| description | <jats:title>Abstract</jats:title><jats:p>Orthostatic hypotension (OH) is a common cause of hospitalization, particularly in the elderly. Hospitalized patients with OH are often severely ill, with complex medical comorbidities and high rates of disability. Droxidopa is a norepinephrine precursor approved for the treatment of neurogenic OH (nOH) associated with autonomic failure that is commonly used in the outpatient setting, but there are currently no data regarding the safety and efficacy of droxidopa initiation in medically complex patients. We performed a retrospective review of patients started on droxidopa for refractory nOH while hospitalized at Vanderbilt University Medical Center between October 2014 and May 2017. Primary outcome measures were safety, change in physician global impression of illness severity from admission to discharge, and persistence on medication after 180‐day follow‐up. A total of 20 patients were identified through chart review. Patients were medically complex with high rates of cardiovascular comorbidities and a diverse array of underlying autonomic diagnoses. Rapid titration of droxidopa was safe and well tolerated in this cohort, with no cardiovascular events or new onset arrhythmias. Supine hypertension requiring treatment occurred in four patients. One death occurred during hospital admission due to organ failure associated with end‐stage amyloidosis. Treating physicians noted improvements in presyncopal symptoms in 80% of patients. After 6 months, 13 patients (65%) continued on droxidopa therapy. In a retrospective cohort of hospitalized, severely ill patients with refractory nOH, supervised rapid titration of droxidopa was safe and effective. Treatment persistence was high, suggesting that symptomatic benefit extended beyond acute intervention.</jats:p> |
| doi_str_mv | 10.1111/jch.13619 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qY2guMTM2MTk |
| imprint | Wiley, 2019 |
| imprint_str_mv | Wiley, 2019 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1524-6175, 1751-7176 |
| issn_str_mv | 1524-6175, 1751-7176 |
| language | English |
| last_indexed | 2024-03-01T18:05:11.659Z |
| match_str | mcdonell2019initiationofdroxidopaduringhospitaladmissionformanagementofrefractoryneurogenicorthostatichypotensioninseverelyillpatients |
| mega_collection | Wiley (CrossRef) |
| physical | 1308-1314 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | The Journal of Clinical Hypertension |
| source_id | 49 |
| spelling | McDonell, Katherine E. Preheim, Brock A. Diedrich, Andre’ Muldowney, James A. S. Peltier, Amanda C. Robertson, David Biaggioni, Italo Shibao, Cyndya A. 1524-6175 1751-7176 Wiley Cardiology and Cardiovascular Medicine Endocrinology, Diabetes and Metabolism Internal Medicine http://dx.doi.org/10.1111/jch.13619 <jats:title>Abstract</jats:title><jats:p>Orthostatic hypotension (OH) is a common cause of hospitalization, particularly in the elderly. Hospitalized patients with OH are often severely ill, with complex medical comorbidities and high rates of disability. Droxidopa is a norepinephrine precursor approved for the treatment of neurogenic OH (nOH) associated with autonomic failure that is commonly used in the outpatient setting, but there are currently no data regarding the safety and efficacy of droxidopa initiation in medically complex patients. We performed a retrospective review of patients started on droxidopa for refractory nOH while hospitalized at Vanderbilt University Medical Center between October 2014 and May 2017. Primary outcome measures were safety, change in physician global impression of illness severity from admission to discharge, and persistence on medication after 180‐day follow‐up. A total of 20 patients were identified through chart review. Patients were medically complex with high rates of cardiovascular comorbidities and a diverse array of underlying autonomic diagnoses. Rapid titration of droxidopa was safe and well tolerated in this cohort, with no cardiovascular events or new onset arrhythmias. Supine hypertension requiring treatment occurred in four patients. One death occurred during hospital admission due to organ failure associated with end‐stage amyloidosis. Treating physicians noted improvements in presyncopal symptoms in 80% of patients. After 6 months, 13 patients (65%) continued on droxidopa therapy. In a retrospective cohort of hospitalized, severely ill patients with refractory nOH, supervised rapid titration of droxidopa was safe and effective. Treatment persistence was high, suggesting that symptomatic benefit extended beyond acute intervention.</jats:p> Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients The Journal of Clinical Hypertension |
| spellingShingle | McDonell, Katherine E., Preheim, Brock A., Diedrich, Andre’, Muldowney, James A. S., Peltier, Amanda C., Robertson, David, Biaggioni, Italo, Shibao, Cyndya A., The Journal of Clinical Hypertension, Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Internal Medicine |
| title | Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_full | Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_fullStr | Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_full_unstemmed | Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_short | Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_sort | initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| title_unstemmed | Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients |
| topic | Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Internal Medicine |
| url | http://dx.doi.org/10.1111/jch.13619 |